P Valet Selected Research

P Valet Research Topics

Disease

15	Obesity 01/2022 - 11/2001
6	Insulin Resistance 01/2022 - 03/2001
4	Body Weight (Weight, Body) 06/2008 - 11/2001
3	Frailty 01/2021 - 01/2020
3	Type 2 Diabetes Mellitus (MODY) 09/2015 - 12/2007
3	Glucose Intolerance 06/2013 - 03/2005
3	Weight Gain 06/2008 - 12/2005
3	Hyperglycemia 12/2005 - 09/2003
2	Neoplasms (Cancer) 09/2015 - 04/2001
2	Hypoxia (Hypoxemia) 12/2008 - 03/2003
2	Hyperinsulinism (Hyperinsulinemia) 06/2006 - 12/2005
1	Cicatrix (Scar) 01/2022
1	Sarcopenia 01/2022
1	Diabetic Cardiomyopathies 01/2021
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	Chronic Disease (Chronic Diseases) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2015
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2015
1	Hypertrophy 02/2015
1	Heart Failure 02/2015
1	Prader-Willi Syndrome (Syndrome, Prader-Willi) 09/2014
1	Inflammation (Inflammations) 12/2007
1	Diabetic Angiopathies (Diabetic Angiopathy) 07/2007
1	Schizophrenia (Dementia Praecox) 06/2007
1	Hyperphagia (Overeating) 06/2007
1	Hypertension (High Blood Pressure) 06/2006
1	Morbid Obesity 12/2005
1	Overweight 12/2005
1	Body Weight Changes 09/2003

Drug/Important Bio-Agent (IBA)

8	ApelinIBA 01/2022 - 12/2007
6	Glucose (Dextrose)FDA LinkGeneric 09/2015 - 03/2003
4	AdipokinesIBA 09/2015 - 12/2005
4	Messenger RNA (mRNA)IBA 05/2014 - 11/2001
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2007 - 03/2003
3	Insulin (Novolin)FDA Link 01/2022 - 09/2003
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
3	Biological ProductsIBA 01/2022 - 04/2001
3	LeptinIBA 12/2013 - 09/2003
3	Oxidoreductases (Dehydrogenase)IBA 06/2008 - 06/2005
3	AminesIBA 06/2008 - 06/2005
2	Peptides (Polypeptides)IBA 01/2022 - 02/2015
2	Monoamine Oxidase (MAO)IBA 06/2008 - 06/2006
2	CytokinesIBA 12/2007 - 03/2005
2	ResistinIBA 12/2005 - 11/2001
2	Aurothioglucose (Gold 50)IBA 03/2005 - 11/2001
1	Growth Differentiation Factor 15IBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Metformin (Glucophage)FDA LinkGeneric 01/2022
1	LigandsIBA 09/2015
1	Growth Hormone (Somatotropin)IBA 09/2014
1	AdiponectinIBA 12/2013
1	LipidsIBA 06/2013
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 06/2013
1	lysophosphatidic acidIBA 06/2013
1	Pargyline (Pargyline Hydrochloride)FDA Link 06/2008
1	carbamylhydrazine (semicarbazide)IBA 06/2008
1	dimemorfan (AT 17)IBA 06/2008
1	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA 06/2008
1	Caffeine (No Doz)FDA LinkGeneric 12/2007
1	Hormones (Hormone)IBA 12/2007
1	Nitric Oxide Synthase (NO Synthase)IBA 07/2007
1	Amine Oxidase (Copper-Containing)IBA 07/2007
1	pimagedine (aminoguanidine)IBA 07/2007
1	Neurotransmitter Agents (Neurotransmitter)IBA 06/2007
1	Haloperidol (Haldol)FDA LinkGeneric 06/2007
1	Histamine Receptors (Histamine Receptor)IBA 06/2007
1	ziprasidone (Geodon)FDA Link 06/2007
1	Olanzapine (Zyprexa)FDA Link 06/2007
1	Antipsychotic Agents (Antipsychotics)IBA 06/2007
1	EnzymesIBA 06/2006
1	benzylamineIBA 06/2005
1	AlloxanIBA 06/2005
1	Rosiglitazone (Avandia)FDA Link 03/2005
1	alkylglycerophosphoethanolamine phosphodiesteraseIBA 03/2005
1	Streptozocin (Streptozotocin)FDA Link 03/2005
1	Nonesterified Fatty Acids (NEFA)IBA 09/2003
1	TyramineIBA 09/2003
1	Triglycerides (Triacylglycerol)IBA 09/2003
1	Actins (F Actin)IBA 03/2003
1	Adrenergic Agents (Adrenergic Drugs)IBA 02/2002
1	SphingomyelinsIBA 03/2001
1	PPAR gammaIBA 03/2001

Therapy/Procedure

1	Transplantation 12/2008